tyrosine expressed at p116, either alone or together with an aspartic acid residue at p114, inhibited HLA-B27 dimerization and increased the assembly rate. F-pocket residues altered the associations with chaperones of the early major histocompatibility complex class I folding pathway. Calnexin was demonstrated to participate in endoplasmic reticulum (ER) stress-mediated degradation of dimers, whereas the oxidoreductase ERp57 does not appear to influence dimerization.
Conclusion. Residues within the F pocket of the peptide-binding groove, which differ between diseaseassociated and non-disease-associated HLA-B27 subtypes, can influence the assembly process and heavychain dimerization, events which have been linked to the initiation of disease pathogenesis.
HLA-B27 is a major histocompatibility complex (MHC) class I molecule that exhibits a strong association with inflammatory arthritic conditions that are collectively referred to as the spondyloarthritides (SpA) (1, 2) . HLA-B27 exhibits an enhanced tendency to misfold and form aberrant dimeric structures (3, 4) . HLA-B27 dimers were initially detected following recombinant protein purification and have subsequently been detected both in various cell lines (5-7) and in patient-derived cell types (8, 9) . HLA-B27 dimer expression has also been correlated with disease incidence in the HLA-B27 rat transgenic model of ankylosing spondylitis (AS) (10) . HLA-B27 heavy-chain dimers were thought to form primarily via an unpaired cysteine at position 67 (7) . Subsequently, we have demonstrated that HLA-B27 dimerization inside cells can also involve the structurally conserved cysteines within the a2 domain of the heavy chain at p101 and p164 (6, 11) .
Two HLA-B27 subtypes, HLA-B*27:06 and 09, exhibit no association with AS (12) (13) (14) , although some contradictory data have previously been reported for HLA-B*27:09 (15, 16) . These 2 subtypes have generated much interest because of their limited sequence differences as compared to the canonical disease-associated subtype HLA-B*27:05. HLA-B*27:09 possesses only a change from aspartic acid to histidine at p116 (D116H), while the 06 subtype expresses a change from histidine to aspartic acid and from aspartic acid to tyrosine at p114 and p116, respectively (referred to herein as 06 F pocket), as compared to HLA-B*27:05. In addition, HLA-B*27:06 expresses an aspartic acid-to-serine and a valine-to-glutamate change at p77 and p152, respectively, as well as an alanine-to-glycine change at p211 within the a3 domain as compared to HLA-B*27:05. The residues expressed by HLA-B*27:06 at p77 and p152 are shared with HLA-B*27:04; however, 04 shares the same F-pocket residues with HLA-B*27:05.
Structurally, p114-116 constitute part of the F pocket of the peptide-binding groove, which binds and determines the carboxy terminal motif of MHC class Iassociated peptides (17) , but it can also influence other anchor positions (18) . The 114-116 region also determines the ability of MHC class I molecules to use tapasin in optimizing the peptide cargo and associate with the peptideloading complex (PLC) during assembly in the endoplasmic reticulum (ER) (19) . Thus, the lack of association of the 06 and 09 subtypes with SpA could support a role for the participation of either antigen presentation or protein folding in disease pathogenesis.
HLA-B27 dimerization within the ER occurs early during MHC class I biosynthesis (5) , and the maturation rate affects interactions between MHC class I heavy chains and pre-PLC-associated chaperones (6) . We previously demonstrated that HLA-B*27:05, 06, and 09 subtypes differ in their cysteine accessibility to thiol-modifying drugs (6, 20) , and we recently characterized the ER-associated degradation (ERAD) pathway of misfolded HLA-B27, which involves the ERAD components ER degradationenhancing a-mannoside-like protein 1 (EDEM-1) and the ERAD-associated E3 ubiquitin protein ligase HRD-1 (8) . We reasoned that if misfolding, particularly heavy chain dimerization, is involved in disease pathogenesis, the HLA-B*27:06 and 09 subtypes should exhibit differences in their biochemical characteristics as compared to HLA-B*27:05.
We set out to test whether differences in 06 and 09 F pocket determine which, if any, of the ER resident chaperones are involved in the dimerization process and how these specific residues affect HLA-B27 folding. We demonstrate a role of calnexin in ER stress-induced ERAD of HLA-B27 dimers, which is consistent with our proposed function of EDEM-1 in dimer degradation (8) . We also show a correlation between maturation rates and dimer formation, especially with F-pocket residues expressed by the HLA-B*27:06 allele.
MATERIALS AND METHODS
Cell lines and antibodies. The rat T cell line C58 (21) and the human T cell leukemia lines CEM and CEM.NKR were maintained at 378C in an atmosphere of 5% CO 2 in RPMI 1640 medium supplemented with 10% fetal bovine serum (Globepharm), penicillin, streptomycin, and L-glutamine (R10 medium). The following transfectants were generated by electroporation at 900 mF and 180V and maintained in R10 medium plus G418 ( HEK 293 cells were maintained in R10 medium and transfected with short hairpin RNA (shRNA) targeted to ER protein 57 (ERp57) in the pSilencer 2.1 vector with the use of Lipofectamine 2000 (both from Life Technologies). Anti-V5 antibody (pK antibody) was obtained from Serotec. Monoclonal antibody HC10, which primarily recognizes unfolded HLA-B and HLA-C molecules, and monoclonal antibody ME1, which recognizes folded HLA-B27, were from our own stocks. AntiBiP and anticalnexin antibodies were obtained from StressGen and anti-ERp57 from Abcam. Anti-BiP, anti-homocysteineinducible ER stress protein (anti-HERP), and anti-GAPDH antibodies were obtained from Santa Cruz Biotechnology. Horseradish peroxidase (HRP)-conjugated goat anti-mouse secondary antibody was obtained from Dako and HRP-conjugated antirabbit monoclonal antibody from Sigma.
Site-directed mutagenesis. For mutagenesis, a V5 Cterminal-tagged complementary DNA (cDNA) encoding the HLA-B*27:05 allele, which had been cloned into the mammalian expression vector pCR3.1 (Invitrogen), was mutated using a polymerase chain reaction (PCR)-based site-directed mutagenesis protocol (QuickChange kit; Stratagene), as previously described (22) .
Pulse-chase experiments. Approximately 5 3 10 6 cells were preincubated for 20 minutes in methionine-free RPMI 1640 (Gibco), labeled for 10 minutes with 7.2 MBq of Tran 35 S-Label (MP Biomedicals), washed, and resuspended in R10 medium. Aliquots were removed at specified times, lysed in 1% Nonidet P40 (NP40) lysis buffer (150 mM NaCl, 10 mM Tris, pH 7.4, 1% NP40), supplemented with 1 mM phenylmethylsulfonyl fluoride, 13 complete protease inhibitors (Roche), and 10 mM Nethylmaleimide (NEM; Sigma). Samples were precleared for 30 minutes with protein A-Sepharose (Sigma), and immunoprecipitated for 1 hour at 48C with pK antibody conjugated to 20 ml of protein A-Sepharose. Samples were resolved on 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels and processed for autoradiography.
Immunoprecipitation. Approximately 5 3 10 6 cells from each cell line were incubated for 20 minutes on ice with 20 mM NEM/phosphate buffered saline (PBS), pH 6.8, followed by lysis in 1% NP40 lysis buffer. Lysates were precleared for 1 hour at 48C, followed by immunoprecipitation for 2 hours at 48C with pK antibody (for MHC class I heavy-chain immunoprecipitations).
Immunoprecipitates were washed 5 times with 0.5 ml of lysis buffer.
Immunoblotting. Samples were resolved on 8% SDS-PAGE, transferred onto nitrocellulose (BA85; Schleicher & Schuell), blocked for 1 hour with 5% skimmed milk powder in PBS/0.1% Tween, and incubated overnight with the respective antibodies, followed by incubation with second-stage HRP-coupled antibodies. Images were revealed by chemiluminescence using SuperSignal Femto (Pierce). Images were developed on a Bio-Rad Fluor-S MultiImager Max imager using Quantity One 1-D analysis software.
Flow cytometry. Approximately 5 3 10 5 cells were incubated for 30 minutes at 48C with monoclonal antibody ME1 or HC10 supernatant, washed in PBS/1% fetal calf serum, and incubated for 30 minutes with fluorescein isothiocyanate-coupled antimouse antibodies, washed, and fixed in 1% paraformaldehyde. Cells were analyzed on a FACSCalibur instrument (Becton Dickinson).
Quantitative PCR (qPCR) analysis. We generated cDNA with the use of oligo(dT) primers and a SuperScript III First-Strand Synthesis kit (Invitrogen) according to the manufacturer's instructions. Probes and primers specific for the spliced and unspliced messenger RNA transcripts for the human X-box binding protein 1 (XBP-1) gene used the sequence NM_005080, and those specific for HLA-B*27:05 used the IMGT/HLA database (accession no. HLA-00225, specific for HLA-B*27:05). Sequences were as follows: for XBP-1,
0 -CAGAATCCATGGGGAGATGTT-3 0 (reverse), and 5 0 -CAGGCCCAGTTGTCACCCCTCCA-3 0 (probe); and for HLA-B*27:05, 5 0 -GACACAGATCTGCAAGGCCA-3 0 (forward), 5 0 -TTGTAGTAGCGGAGCAGGGTC-3 0 (reverse), and 5 0 -CGCAGGTCCTCTCGGTCAGTCTGTG-3 0 (probe). Probes and primers for the human b-actin gene were obtained from Applied Biosystems (catalog no. 4333762T). A total of 50 ng of cDNA was tested in duplicate. Real-time PCR was performed using the following conditions: 958C for 10 minutes, with 40 cycles of 958C for 15 seconds and 648C for 1 minute. Figure 1 . Illustration of p114 and p116 residues within the HLA-B27 antigen-binding groove and expression of the p114-116 F-pocket HLA-B27 molecules in the rat thymoma C58 cell line. A, The HLA-B*27:05 antigen-binding groove, as generated with the iCn3D viewer using structure 1HSA. Position 114 is shown in blue and position 116 in green. B, Expression of HLA-B*27:05, H114D, HLA-B*27:09, D116Y, and 06 Fpocket molecule at the cell surface of C58 rat thymoma cells as compared with the untransfected (UT) C58 cell line, as determined by flow cytometry with HC10 and ME1 monoclonal antibodies. C, Protein quantification of F-pocket mutants relative to HLA-B*27:05. C58 cell lines expressing HLA-B*27:05, the HLA-B27 F-pocket mutants, and untransfected C58 cell line were lysed, and equivalent concentrations of protein were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under nonreducing conditions. Lysates were immunoblotted for expression of major histocompatibility complex class I heavy (H) chain and compared with that of GAPDH.
RESULTS
Characterization of cells expressing F-pocketmutated HLA-B27 molecules. The locations of positions 114 and 116 in the F pocket, where the key polymorphisms between the HLA-B*27:05, 06, and 09 subtypes reside, are shown in Figure 1A . We generated sets of C-terminal V5-tagged HLA-B27 molecules with single-residue substitutions found in different subtypes (i.e., B27.H114D, B27.D116Y, B27.D116H [equivalent to the 09 subtype]) or in combination (i.e., B27.H114D.D116Y [06-like; referred to hereinafter as 06 F pocket]) and expressed these in the rat thymoma C58 cell line. The C58 line has an RT1 u MHC background that is also shared with the PVG rat strain, which develops AS-like disease in the presence of HLA-B27 (23, 24) . The RT1 u transporter associated with antigen processing (TAP) confers a more restrictive peptide transport profile than human TAP does and is biased toward peptides that have only hydrophobic C-termini (25) . We reasoned that this more-restricted TAP background might reveal factors that influence HLA-B27 assembly.
Analysis of cell surface expression of HLA-B*27:05 and the p114-116 subtype polymorphisms using the monoclonal antibodies ME1 (detects folded HLA-B27) and HC10 (detects partially unfolded HLA-B and C molecules) indicated that residues expressed at p114-116 can alter cell surface expression in the RT1 u MHC background. The H114D substitution led to a reduction in cell surface expression ( Figure 1B ). HC10 expression overall mirrored that of ME1. Quantitative PCR (data not shown) and protein expression analyses demonstrated that except for HLA-B*27:09, all mutants were expressed within 3-fold of the expression of the HLA-B*27:05 subtype. In addition, these data indicate that the reduced cell surface expression of H114D we observed was not the result of a deficit of HLA-B27 heavy-chain expression ( Figure 1C ).
Influence of residues at p114-116 on the association with chaperones. It was previously demonstrated that HLA-B*27:05 dimerization occurs soon after translation (ref. 5 and Antoniou AN, et al: unpublished observations) and that F-pocket residues can affect MHC class I assembly (26); therefore, it is possible that ER-resident chaperones associating with newly synthesized proteins may influence how these dimers are generated. The HLA-B27 heavy chain was immunoprecipitated and then immunoblotted for analysis of coprecipitating ER-resident chaperones to determine which, if any, of these residues influenced ER-resident chaperone associations. Cells expressing HLA-B*27:05 and p114-116 substitutions were incubated with NEM to preserve transient disulfide bond interactions, lysed, and immunoprecipitated through the anti-V5 epitope, resolved by nonreducing SDS-PAGE, and immunoblotted for ERp57, calnexin, BiP, calreticulin (data not shown), protein disulfide isomerase (PDI; data not shown), and tapasin (data not shown).
HLA-B*27:05, H114D, and HLA-B*27:09 formed conjugates with ERp57 and associated with calnexin and BiP ( Figure 2 ). The ERp57 immunoblot analysis also Figure 2 . Alteration of endoplasmic reticulum (ER) chaperone associations by residues 114-116 of HLA-B27. Top, Untransfected C58 cells and cells expressing HLA-B*27:05 and subtype polymorphisms H114D, HLA-B*27:09, D116Y, and the 06 F pocket were immunoprecipitated (IP) through the V5 tag and immunoblotted for ER protein 57 (ERp57) (top), calnexin (middle), and BiP (bottom). Immunoblotting detected the ERp57 disulfide-bonded conjugates with HLA-B*27:05, H114D, and HLA-B*27:09 (b-f) as well as ERp57 monomer (a). Immunoblotting shows calnexin and BiP coprecipitating with HLA-B*27:05, H114D, and HLA-B*27:09. Bottom, Reduced lysates from these cell lines were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotted with ERp57, calnexin (CNX), and BiP, illustrating equal loading. Reduced lysates were also probed for HLA-B27 heavy (H) chain using the V5 tag, and immunoblotting indicates approximately equal levels of major histocompatibility complex (MHC) class I heavy chain except for HLA-B*27:09. Results from 1 of 4 independent experiments are shown.
IMPACT OF F-POCKET POLYMORPHISMS ON HLA-B27 SUBTYPE FOLDINGrevealed several high molecular mass ERp57-MHC class I heavy-chain conjugates (Figure 2 , bands b-f) as well as ERp57 monomers (Figure 2, band a) . The ERp57-B27 conjugates were of different sizes from the HLA-B27 heavy-chain dimers (data not shown). In contrast, there was lower association of these chaperones with the D116Y and 06 F-pocket heavy chains. No association between HLA-B27 and PDI, calreticulin, and tapasin (data not shown) could be detected under these experimental conditions; this is likely due to the use of NP40, which does not preserve most PLC interactions (27) . Thus, F-pocket differences among HLA-B27 subtypes 05, 06, and 09 can influence associations with the chaperones calnexin and BiP and with the oxidoreductase ERp57, which can associate with newly synthesized proteins (28) .
Regulation of HLA-B27 heavy-chain dimer formation by calnexin and F-pocket residues. Calnexin can control both the degradation and folding of substrate proteins, including MHC class I molecules (29) (30) (31) . We have previously shown that EDEM-1 is involved in the ERAD of HLA-B27 dimers (8) , with calnexin integral to its function (32, 33) . We therefore hypothesized that calnexin may play a pivotal role in HLA-B27 dimerization. To examine the role of calnexin, we used the calnexin-deficient human cell line CEM.NKR. We transfected both the parental calnexin-expressing cell line CEM and CEM.NKR with HLA-B*27:05, 06 F pocket, and as a control, the nondisease-associated MHC class I molecule HLA-A*02:01. The respective cell lines were treated with NEM, lysed, and the proteins were resolved by SDS-PAGE. Immunoblotting for MHC class I heavy chain revealed that HLA-B*27:05 produced dimer populations in CEM cells, while the control HLA-A*02:01 did not ( Figure 3A) . In NKR cells, HLA-B*27:05 displayed enhanced dimer formation. We could not detect dimers in either CEM or CEM.NKR cells expressing HLA-B*27:06 F-pocket heavy chain (Figure 3A) . Protein expression and quantitative PCR analysis revealed that both CEM.B27 and NKR.B27 cell lines expressed similar levels of transfected HLA molecules (data not shown). The failure of HLA-A*02:01 to form dimer populations in normal or calnexin-deficient cell lines indicates that the absence of calnexin does not, of itself, cause the formation of HLA aggregates. These observations suggest that calnexin inhibits and/or reduces the formation of HLA-B27 dimers.
Assembly of HLA-B27 in the absence of calnexin. The above data suggest that calnexin regulates heavy-chain dimers. We next studied the impact of calnexin deficiency on the expression and kinetics of HLA-B27 assembly. The cell surface expression of ME1-and HC10-reactive forms of HLA-B27 was determined. HLA-B*27:05 was similarly expressed by both CEM.B*27:05 and NKR.B*27:05 lines and as detected by ME1, whereas HC10 staining was ;2-fold less in the absence of calnexin (Figures 3B and C) . Thus, there are more partially folded or misfolded molecules at the cell surface in the presence of calnexin.
We next analyzed the assembly kinetics by performing pulse-chase experiments. HLA-B*27:05 displayed little acquisition of endoglycosidase H (endo H) resistance over 3 hours of chase, both in wild-type or calnexin-deficient cells ( Figure 3D ). Over a longer time course, endo H-resistant material appeared at 3.5 hours both in the wild-type and the calnexin-deficient cells, with a slight increase in endo H-resistant material in the presence of calnexin. This was quantified as 38% and 46% endo H-resistant at 3.5 hours and 5 hours, respectively, in CEM cells as compared to 17% and 28%, respectively, in NKR cells ( Figure 3E) . Thus, the presence of calnexin promoted faster assembly kinetics, but paradoxically, this may result in less-stable molecules which dissociate more readily at the cell surface.
HLA-B*27:05 heavy-chain dimer detection is not dependent on ERp57, while ERAD is modulated by calnexin. Calnexin binds and recruits the oxidoreductase ERp57 (34); thus, the absence of calnexin could potentially disrupt HLA-B*27:05 associations with ERp57, Figure 4 . No influence of endoplasmic reticulum protein 57 (ERp57) on heavy-chain dimer formation, but calnexin modulation of dimer degradation via ER stress-induced ER-associated degradation (ERAD). A, CEM, NKR, CEM.B*27:05, and NKR.B*27:05 cells were immunoprecipitated (IP) for HLA-B27 with the V5 tag antibody and immunoblotted for ERp57. HLA-B27-ERp57 conjugates were detected in the CEM.B27 and NKR.B27 cell lines. B, ERp57 in 293T cells was mock inhibited or was stably inhibited with the use of short hairpin RNA, and lysates were immunoblotted for ERp57, protein disulfide isomerase (PDI), ERp72, calreticulin (CRT), and calnexin (CNX). C, Wild-type (WT) and ERp57-knockdown 293T cells were left untransfected (UT) or were transiently transfected with HLA-B*27:05. Lysates were probed for major histocompatibility complex (MHC) class I heavy chain using HC10 antibody. D, There is degradation of heavy-chain dimers via unfolded protein response (UPR)-induced ERAD in the presence, but not the absence, of calnexin. CEM.B27 and NKR.B27 cells were treated with 0.1 or 1.0 mg/ml of tunicamycin (TUN), and lysates were immunoblotted for HLA-B27 using the V5 antibody. Untreated (0) cells and mock (M)-treated cells incubated with DMSO alone are shown for comparison. E, Induction of the UPR in the presence and absence of calnexin was determined in CEM and NKR cells. Cells were incubated with 5 mM dithiothreitol (DTT), RNA was extracted, and quantitative reverse transcription-polymerase chain reaction of the X-box binding protein 1 spliced (XBP-1s) product was performed. Values are the mean 6 SD. F, CEM and NKR cells were treated with TUN, and lysates were immunoblotted for BiP, homocysteine-inducible ER stress protein (HERP), and GAPDH. which may affect dimerization. We therefore immunoprecipitated MHC class I heavy chains from both CEM.B*27:05 and NKR.B*27:05 lines and immunoblotted for ERp57 associated with HLA-B27 ( Figure 4A ). ERp57 was associated with HLA-B*27:05 in both wild-type and calnexin-deficient cells. To determine if heavy chain dimerization was influenced by ERp57, we stably inhibited ERp57 in 293T cells with the use of shRNA ( Figure 4B ), followed by transient transfection with HLA-B*27:05. In the absence of ERp57, HLA-B27 retained the ability to dimerize ( Figure 4C) ; however, minor alterations in the pattern of dimers were observed in ERp57-deficient cells, suggesting that ERp57 may influence the composition of the dimerized pool.
Calnexin participates in the degradation of misfolding polypeptide substrates in conjunction with the ER stress-associated EDEM-1 protein (33). We therefore examined whether enhanced dimer levels were a result of reduced degradation in the absence of calnexin. CEM.B*27:05 and NKR.B*27:05 cells were treated with tunicamycin, which causes ER stress-induced ERAD responses (8) . In the presence of calnexin, HLA-B27 dimers were absent following ER stress induction, but in the absence of calnexin, heavy-chain dimers were retained ( Figure 4D ). To discount the possibility that calnexin-deficient cells were unable to induce an ER stress response, we treated cells with tunicamycin or dithiothreitol and monitored the unfolded protein response (UPR) activation marker BiP, the XBP-1 spliced (XBP-1s) transcription factor, and HERP, which is activated by XBP-1s. Pharmacologic induction of ER stress led to enhanced expression of BiP (2.9-fold and 5.4-fold increase in CEM and NKR, respectively) and HERP (1.2-fold and 1.9-fold increase in CEM and NKR, respectively), as detected by immunoblotting, Figure 5 . Alteration of the ability of HLA-B27 to mature and dimerize by F pocket p114-116 residues. A, Lysates from C58 cells expressing HLA-B*27:05, HLA-B*27:09, D116Y, H114D, and HLA-A*02:01 were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under nonreducing conditions and immunoblotted for the V5 tag. The D116Y substitution exhibits a reduced tendency to dimerize (top). C58 cells expressing D116Y and 06 F pocket were incubated overnight at 378C or 268C. Lysates were then resolved by SDS-PAGE under nonreducing conditions and immunoblotted for the V5 tag. D116Y and 06 F pocket exhibit a reduced tendency to dimerize at 378C, while both can dimerize following incubation at reduced temperature (bottom). B, Pulse-chase analysis of HLA-B*27:05 and subtype polymorphisms H114D, HLA-B*27:09, D116Y, and 06 F pocket. Cell lines were metabolically labeled, chased for 0, 45, or 90 minutes, immunoprecipitated with the anti-V5 antibody, and resolved by SDS-PAGE under reducing conditions. HLA-B*27:09, D116Y, and 06 F pocket exhibit more rapid acquisition of endoglycosidase H (endo H sensitive [s]). Results from 1 of 3 experiments are shown. r 5 endo H resistant.
as well as enhanced levels of XBP-1s transcript, as determined by qPCR. Therefore, in the absence of calnexin, the UPR can be induced (Figures 4E and F) .
Altered dimerization and maturation kinetics of HLA-B27 by residues at p114-116. The above analysis demonstrated that F-pocket residues can influence chaperone associations. We previously hypothesized that the rate of maturation can correlate with dimer formation (6); therefore, we examined how the F-pocket residues influenced HLA-B27 dimerization in rat C58 cells. D116Y had a reduced tendency to dimerize ( Figure 5A, top) , as did the 06 F-pocket mutant ( Figure 5A, bottom) . After overnight incubation at 268C to slow the assembly kinetics, both the D116Y and 06 F-pocket mutants displayed an ability to dimerize ( Figure 5A, bottom) , indicating there were no overall structural constraints preventing dimerization.
We previously demonstrated that the ability of HLA-B27 to dimerize correlated with the assembly kinetics (6); therefore, we determined the effect of each of the F-pocket residues on the assembly kinetics of HLA-B27 ( Figure 5B ). Cells expressing HLA-B*27:05, B27.H114D, HLA-B*27:09, D116Y, and 06 F-pocket were analyzed in pulse-chase experiments. We used an anti-V5 antibody directed at the C-terminus for immunoprecipitation and were therefore able to detect all HLA-B27 molecules in an unbiased manner. Only a small proportion of the total , calnexin is displaced. HLA-B27 can acquire an optimal peptide cargo through the association with the peptide-loading complex (PLC), whose predominant constituents are the transporter associated with antigen presentation (TAP), tapasin (TPN), ERp57, and calreticulin (CRT) (19, 28) . HLA-B27 can transit to the cell surface independently of the PLC. HLA-B*27:05 can also form heavy-chain dimers, which can potentially activate the unfolded protein response (UPR) (11) . The UPR-induced transcription factor X-box binding protein 1 (XBP-1) can target genes with a UPR element (UPRE) promoter sequence (50) . ER degradation-enhancing a-mannoside-like protein 1 (EDEM-1) and ER-associated degradation (ERAD)-associated E3 ubiquitin protein ligase (HRD-1) can be activated by XBP-1, and together with suppressor of Lin12-like 1 (SEL-1), form an ER stress-induced protein degradation complex (8) . Through the action of calnexin, heavy-chain dimers can be targeted for destruction via the ER stress-induced degradation complex. B, The 06 F pocket and D116Y residues result in transient associations with the chaperones calnexin-ERp57 and BiP. Both exhibit a fast maturation rate (30-45 minutes) of folded HLA class I molecules (40) , resulting in the formation of little, if any, heavy-chain dimers. C, HLA-B*27:09 exhibits a slower maturation rate (90 minutes), which can result in the formation of both folded and dimeric conformers. D, HLA-B*27:05 and H114D exhibit exposed and reactive cysteines (depicted by ??) to a greater extent than HLA-B*27:09 (depicted in C by ?) (20) . Both these molecules have an enhanced tendency to misfold and form heavy-chain dimers, while exhibiting prolonged associations with calnexin-ERp57 and BiP. HLA-B*27:05 molecules transit through the ER at a slow rate (3.5 hours). The times (in minutes or hours) in B-D are maturation rates of HLA-B27 heavy chains, as determined by acquisition of endoglycosidase H resistance.
IMPACT OF F-POCKET POLYMORPHISMS ON HLA-B27 SUBTYPE FOLDING
HLA-B*27:05 and H114D molecules (3% and 0.5%, respectively) acquired endo H resistance after 90 minutes of chase ( Figure 5B ), indicating that they remained within the ER for prolonged periods. However, residue changes at p116 dramatically changed the maturation rates. HLA-B*27:09 (10% endo H resistant at 90 minutes) had a markedly faster maturation rate than HLA-B*27:05, while the D116Y substitution was sufficient to further dramatically alter the maturation kinetics (29% at 90 minutes). The 06 F-pocket-expressing HLA-B27 molecule exhibited an even faster maturation rate than did the D116Y mutant (50% at 90 minutes). Therefore, residues at p114-116 in the F pocket can have a dramatic effect on the maturation rate of HLA-B27.
DISCUSSION
The role played by HLA-B27 in the pathogenesis of inflammatory arthritis remains elusive. Our data indicate that the residues at p114-116 dramatically affect the folding and dimer-formation characteristics of HLA-B27 (summarized in Figure 6 ). Much of the focus regarding dimerization has centered around C67; however, our earlier observations and those of others suggested that C67 is not the sole cysteine responsible for dimerization and that C164 may also participate in this process (6, 11) . We previously demonstrated that p114-116 of HLA-B27 was also important in determining whether cysteine residues were exposed and reactive (20) (Figures 6C and D) . The reduced tendency of D116Y and 06 F-pocket mutant heavy chains to dimerize may be related to the temporal exposure of reactive cysteines to the oxidizing environment of the ER ( Figure 6B ). Thus, together with the residues expressed at p114-116, the unpaired and structural cysteines proposed to be involved in dimerization may result in the ER resident population of heavy-chain dimers being a complex mix of disulfide species involving multiple cysteine residues.
It has also been proposed that HLA-B27 dimers at the cell surface and within the cell may play a distinct role in disease pathogenesis (3, 35) . ER-resident dimers have been hypothesized to induce ER stress responses, possibly leading to proinflammatory cytokine production (35, 36) . In contrast, cell surface dimers lead to aberrant recognition by immune receptors (37, 38) . In preliminary experiments with the HD6 antibody reagent, which identifies cell surface HLA-B27 dimeric structures (39), we found no significant effect of the position 114 and 116 variants studied here, further supporting the idea that the cell surface HLA-B27 dimers are distinct from the ER-resident forms (data not shown).
These current observations indicate that residues within the peptide-binding groove, representing polymorphisms found in HLA-B27 subtypes not associated with disease, play a critical role in determining the maturation rate of the molecule. The findings of earlier work using conformationally specific antibodies ME1 and W6/32 (40, 41) corroborate our unbiased approach of monitoring HLA-B27 molecules expressing F-pocket changes. Those studies demonstrated that polymorphisms at p116 enhanced the acquisition of W6/32 and ME1 epitopes as well as affected the ratio of folded versus HC10-reactive populations. Therefore, we suggest that the maturation rate of the HLA-B27 molecule influences whether cysteine residues are exposed to the oxidizing environment of the ER long enough to participate in aberrant disulfide bonding ( Figures 6B and D) .
The aspartic acid residue at p114 is expressed together with a tyrosine at p116 by HLA-B*27:06. However, the H114D mutation alone has a dramatic effect on cell surface expression levels of HLA-B27 as compared to HLA-B*27:05 ( Figure 1B) , a finding consistent with previous observations (40) . Interestingly, expression is restored to wild-type levels at reduced temperatures (ref. 40 and Antoniou AN, et al: unpublished observations), which indicates that there are probably no gross primary structural alterations. Recently, biophysical and biochemical studies suggested that the HLA-B*27:05 and 04 peptidebinding grooves exhibit greater degrees of flexibility and disorder as compared to HLA-B*27:06 and 09 (42, 43) . It is possible that the cell surface expression levels that we observed in our peptide-restricted environment could be a reflection of the level of disorder within the HLA-B27 peptide-binding groove. The expression of tyrosine or histidine at p116 could reduce disorder (43) , which may enhance peptide-binding stability, leading to improved folding dynamics and, subsequently, enhanced cell surface expression. However, the expression of aspartic acid at p114 in combination with an aspartic acid at p116 could increase the molecular disorder of the binding groove and disrupt the stability of peptide-MHC complexes.
Y116 appears to rescue or be dominant in its effect on HLA-B27 folding, which highlights the fact that certain combinations of residues can influence MHC class I assembly (40, 44) . Our observations highlight how the Fpocket residues of HLA-B*27:06 affect the early stages of folding and dimerization. However, it would be of interest to determine any further effects of the HLA-B*27:06 serine and glutamate residues at p77 and p152, respectively. We can postulate that evolutionary pressure on MHC polymorphisms can select for combinations of residues not only to enable the effective presentation of peptide, but also to allow for efficient folding and expression of 618 GUILIANO ET AL MHC class I molecules. The above findings indicate that predicting the actual outcome of multiple mutations within the antigen-binding groove on MHC class I molecules is difficult. Intriguingly, the tyrosine at p116 is shared with HLA-B*27:07, which has been described as a subtype that is both associated and not associated with AS. However, many studies suggest that HLA-B*27:07 exhibits a weaker association with AS (45, 46) . Studies have demonstrated that HLA-B*27:07 and 06 can oligomerize to different extents (47) . It remains undetermined how an asparagine at p114 in the absence of tyrosine as well as how the HLA-B*27:07 F pocket can affect the biochemical parameters we have described here. Our findings are consistent with previous observations that Y116 does enhance the maturation rate (44), but whether this is an important parameter in AS development remains undetermined. Our analysis does reveal differences in maturation rates and levels of dimerized HLA-B27 molecules. These observations could reflect differences between the rat C58 line with a restricted HLA-B27-binding peptide repertoire compared to human B and T lymphoblastoid lines, such as CIR and 174.221.
HLA-B27 polymorphisms expressed at p114-116 can influence chaperone associations. These residues were thought to determine the requirement for tapasin within the PLC (19) . In relation to HLA-B27, it has been reported that polymorphisms expressed within the peptide-binding groove by HLA-B27 subtypes influence thermostability (41, 48) , F-pocket flexibility (43) , and the requirement for tapasin (40) . In the present study, we extend these findings to chaperones associated with early folding events ( Figure 6 ). It is possible that MHC class I heavy-chain levels could influence chaperone associations. The higher levels of HLA-B*27:09 expression (Figure 1 ) could indeed account for the coprecipitation of BiP, calnexin, and ERp57 with this molecule. D116Y and the 06 F-pocket mutants, although expressed ;3-fold higher than HLA-B*27:05, exhibited only minimal, if any, expression of the coprecipitating chaperones (Figure 2) .
We previously demonstrated that chaperone associations may depend on the MHC class I allele and rate of maturation. Incubation at reduced temperature can enhance chaperone associations (6) . By reducing the temperature to 268C, both D116Y and the 06 F-pocket heavy chains could dimerize ( Figure 5) , and under these conditions, calnexin, BiP, and ERp57 could be detected (Antoniou AN, et al: unpublished observations). These observations suggest that the folding and misfolding characteristics of MHC class I heavy chains are a predominant influence on chaperone association. Therefore, our data demonstrate that residues at p114 and p116 can influence associations with the oxidoreductase ERp57 and the chaperones, calnexin and BiP (Figure 2 ), which are involved in both early folding events of secretory proteins and their degradation (28, 49) .
Our analysis of the role of ERp57 in HLA-B27 dimer formation in NKR.B27 cells indicates that this oxidoreductase does not require calnexin to associate directly with MHC class I heavy chains. We observed that ERp57 formed disulfide-bonded conjugates with HLA-B27 heavy chains predisposed to forming dimeric conformations. However, ERp57 inhibition revealed that dimers could still be detected in the absence of ERp57. It is possible that dimerization is a spontaneous event that is mediated by the oxidizing conditions of the ER. However, heavy-chain dimerization could also be mediated by other oxidoreductases, such as PDI. Future studies using dual inhibition of ERp57 and PDI in HLA-B27-expressing cells would address this question.
The findings of this study also support a key role of calnexin in modulating dimer levels ( Figure 6A ). In the absence of calnexin, dimer levels were enhanced ( Figure  3 ). Our analysis also revealed that calnexin can mediate the degradation of dimers following the induction of ER stress ( Figure 4D ). These results are consistent with our previous observations demonstrating a role of EDEM-1 in the degradation of HLA-B27 dimers (8) . EDEM-1 appears to require calnexin for efficient degradation of misfolding proteins (33) , and EDEM-1 is also a target for the ER stress-inducible XBP-1s transcription factor (50) . Therefore, our observations are consistent with a role of calnexin and EDEM-1 in mediating dimer levels via an ER stress degradation pathway ( Figure 6A ).
While the rat C58 cell line used in this study is unlikely to exactly represent the normal situation in human cells because of its restricted TAP peptide transporter phenotype, it allowed us to reveal key constraints imposed upon HLA-B27 assembly due to the residues at p114-116. The 06 and 09 subtypes share overlapping peptide repertoires with HLA-B*27:05 (51, 52) . Situations where peptide supply might become a more limiting factor could arise in human cells, such as those expressing some of the ER aminopeptidase 1 (ERAP-1) polymorphisms associated with AS (53) . It has been suggested that ERAP-1 polymorphisms do not affect ER stress in AS patients, as determined by the expression of the early and late markers Grp78 and CCAAT/enhancer binding protein homologous protein 10, respectively (54) . However, our previous observations suggest that there is an ER stress "footprint" in samples from AS patients, as determined by the expression of HRD-1 (8) . Thus, the detection of ER stress could be dependent on time and disease state, as well as on the marker and cell type being analyzed. Alternatively, if normal cellular homeostasis is disrupted, perhaps during viral or bacterial infections, or even just immune cell activation (55) , this may also impose restrictions or alterations on peptide supply, which then influence MHC class I peptide loading and maturation. Under these circumstances, heavy-chain dimer formation could be enhanced and trigger an ERAD response to help clear the pool of misfolded heavy chains.
Our study demonstrates one of the first clear mechanistic links between subtype polymorphisms within the F pocket of the peptide-binding groove, the disease incidence, and the biochemical properties of these HLA-B27 molecules. Our observations highlight the fact that Fpocket residues can affect dimerization and chaperone association and can alter the maturation rates of HLA-B27 subtypes. The pattern of dimerization and chaperone association correlates with HLA-B*27:06 and its lack of association with AS, suggesting that these parameters may explain why HLA-B27:06 does not lead to an inflammatory situation. In addition, we have shown that ER stress induction can lead to calnexin-dependent dimer degradation and that exploiting the UPR-induced ERAD pathway could well be a potential novel therapeutic approach.
